HCW Biologics Inc. reported the settlement and extinguishment of $2.8 million in disputed accounts payable, including a $1.1 million lien satisfaction from B&I Contractors, Inc. and the full payment of a $1.2 million settlement with EirGenix, Inc. regarding manufacturing costs. HCW Biologics Inc. is a biotechnology company focused on the development and manufacturing of biologics.
